---
name: SSRI Thiazide without low sodium with hyponatremia drug risk

data:
-
  resourceType: Patient
  name: Fuller Jackson
  gender: male
  birthDate: 1955-02-16
-
  resourceType: MedicationStatement
  code: RXNORM#794947 Sertraline 150 MG Oral Tablet
  effectiveDateTime: 2019-07-30T00:00:00.000+00:00
-
  resourceType: MedicationStatement
  code: RXNORM#197499 Chlorthalidone 25 MG Oral Tablet
  effectiveDateTime: 2019-08-31T00:00:00.000+00:00
-
  resourceType: Observation
  code: LOINC#2947-0 Sodium [Moles/volume] in Blood
  valueQuantity: 140 mmol/L
  issued: 2019-09-15T00:00:00.000+00:00
-
  resourceType: MedicationStatement
  code: RXNORM#834348 amiodarone hydrochloride 400 MG Oral Tablet
  effectiveDateTime: 2019-08-15T00:00:00.000+00:00

results:
  Summary:
    Patient:
      Name: Fuller Jackson
      Gender: male
      Age: 64
    HistoricalTreatments:
      SSRIsSNRIs:
      -
        Type: Statement
        Name: Sertraline 150 MG Oral Tablet
        Start: '2019-07-30T00:00:00.000+00:00'
        End: null
        Status: active
      Thiazides:
      -
        Type: Statement
        Name: Chlorthalidone 25 MG Oral Tablet
        Start: '2019-08-31T00:00:00.000+00:00'
        End: null
        Status: active
      HighestRecentSodiumConcentration:
      -
        unit: 'mmol/L'
        value: 140
    GeneralRiskFactors:
      Is65orOlder: false
      IsFemale: false
    RiskFactorsForHyponatremia:
      MedicationRiskFactors:
      -
        Type: Statement
        Name: amiodarone hydrochloride 400 MG Oral Tablet
        Start: '2019-08-15T00:00:00.000+00:00'
        End: null
        Status: active
      ConditionRiskFactors: []
    Alert:
      Recommendation: 'Consider alternative. If combination is used, monitor serum sodium'
      Rationale: 'Likely increased risk of hyponatremia'
      Classification: 'Minimize Risk'
      Indicator: 'warning'
